MARK FURLONG
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
DANIEL BARRY, DAVID M. BRACKETT, EDWIN D. CASS, MICHAEL CHIRILLO, DAVID COLLA, NATALIE CRAMPTON, BRUCE FRANK, BARRY J. GIARRAPUTO, JOHN GRAHAM, MELINA HIGGINS, MICHAEL B. LEVITT, TYLER W. LINDBLAD, TIMOTHY G. LYNE, DANIEL MULLINS, DIANE NORDIN, ANDREW PACKER, GEOFFREY RUBIN, ANTHONY SCIACCA, KELLY SHEN, JAMES VAN PELT, PARAS VIRA
DIRECTOR
JOSEPH P. APERFINE, JR., JASON D. AROESTY, STEVEN M. ASAKOWICZ, WILLIAM A. AYLESWORTH, MICHAEL A. BENT, PETER EIO, STEVEN M. EYL, G. IRWIN GORDON, CATHERINE GRASSMAN, ROBERT B. GRIEVE, PH.D., SCOTT HUMPHREY, SHARON LARSON, ROD A. LIPPINCOTT, RODNEY A. LIPPINCOTT, LOUISE L. MCCORMICK, MICHAEL J. MCGINLEY, PH.D., JOHN MCMAHON, JASON A. NAPOLITANO, SHARON RILEY, SHARON L. RILEY, DAVID SVEEN, DAVID E. SVEEN, PH.D., BONNIE J. TROWBRIDGE, KEVIN S. WILSON, NANCY WISNEWSKI, NANCY WISNEWSKI, PH.D., CAROL WRENN, CAROL A. WRENN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
OVER $100,000,000
Equity
2020-03-30

